Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-088618
Filing Date
2025-06-20
Accepted
2025-06-20 18:40:10
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4511
  Complete submission text file 0000950170-25-088618.txt   5969
Mailing Address C/O JANUX THERAPEUTICS, INC. 11099 N. TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address
Simson Jake (Reporting) CIK: 0001863094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42382 | Film No.: 251062641

Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Issuer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)